Promoting Donor Care

A global biovigilance scheme

WMDA operates a global, independent, professionally-led biovigilance scheme. Since 2003, WMDA has collected and analysed anonymised information on adverse events and reactions in stem cell donation and transfusion from organisations involved in the provision of cells. When risks are identified, WMDA produces recommendations to improve donor and patient safety,  documented in the annual report which is then circulated to all relevant professional bodies and WMDA member organisations. As biovigilance is an ongoing exercise, WMDA monitors the implementation of recommendations made to ensure donor care through its accreditation programme.

The Donor Care Pillar of WMDA is oversees the biovigilance programme, ensuring donor protection for all types of donations even years after.

Join WMDA today, and register as service member.

Webshoprelated items